title: Is ranolazine an antiarrhythmic drug?
authors: Division of Cardiovascular Medicine, University of Wisconsin, Madison, WI 53792, USA.
authors: Lee L
authors: LL
authors: Eckhardt
authors: Tom C
authors: TC
authors: Teelin
authors: Craig T
authors: CT
authors: January
mesh_terms: D000083:Acetanilides / Q000494:pharmacology / Q000627:therapeutic use*; D000200:Action Potentials; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002118:Calcium / Q000378:metabolism; D002316:Cardiotonic Agents / Q000494:pharmacology; D002614:Chelating Agents / Q000494:pharmacology; D006325:Heart Atria / Q000187:drug effects / Q000378:metabolism; D006329:Heart Conduction System / Q000187:drug effects* / Q000378:metabolism / Q000503:physiopathology; D006801:Humans; D032383:Myocytes, Cardiac / Q000187:drug effects / Q000378:metabolism; D010879:Piperazines / Q000494:pharmacology / Q000627:therapeutic use*; D000069458:Ranolazine; D012964:Sodium / Q000378:metabolism; D026941:Sodium Channel Blockers / Q000494:pharmacology; D015222:Sodium Channels / Q000187:drug effects / Q000378:metabolism; D013617:Tachycardia, Supraventricular / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D013997:Time Factors; D015854:Up-Regulation
chemical_list: D000083:Acetanilides; D000889:Anti-Arrhythmia Agents; D002316:Cardiotonic Agents; D002614:Chelating Agents; D010879:Piperazines; D026941:Sodium Channel Blockers; D015222:Sodium Channels; D012964:Sodium; D000069458:Ranolazine; D002118:Calcium